PI
AVDL

PineBridge Investments’s Avadel Pharmaceuticals AVDL Stock Holding History

PineBridge Investments’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,478
Closed -$40.8K – 704
2023
Q2 		$40.8K Sell
2,478
-1,644
-40% -$21.4K ﹤0.01% 678
2023
Q1 		$37.8K Sell
4,122
-3,187
-44% -$26.2K ﹤0.01% 614
2022
Q4 		$52.3K Hold
7,309
– – ﹤0.01% 556
2022
Q3 		$37K Hold
7,309
– – ﹤0.01% 579
2022
Q2 		$18K Buy
7,309
+6,009
+462% +$24.7K ﹤0.01% 678
2022
Q1 		$9K Buy
+1,300
New +$8.94K ﹤0.01% 631

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

PineBridge Investments's AVDL Position: Q3 2023 in Review

PineBridge Investments sold out of Avadel Pharmaceuticals (AVDL) in Q3 2023, closing a stake of 2,478 shares — an estimated $40.8K sold.

PineBridge Investments first reported a position in AVDL in Q1 2022 and held it in 6 quarters. The position peaked at $52.3K in Q4 2022. 99 funds tracked by Wall St. Rank hold AVDL as of Q3 2023.

  • PineBridge Investments reported no remaining Avadel Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • PineBridge Investments sold 2,478 Avadel Pharmaceuticals shares in Q3 2023, an estimated $40.8K.
  • PineBridge Investments first reported a position in Avadel Pharmaceuticals in Q1 2022 and held it in 6 quarters.
  • PineBridge Investments's Avadel Pharmaceuticals position peaked at $52.3K in Q4 2022.
  • 99 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2023.

Based on PineBridge Investments's 13F filing for Q3 2023, filed 14 Nov 2023.